Skip to content

A clinical study on the correlation between medical test indexes and response and toxic and side effects of malignant tumors immunotherapy

A clinical study on the correlation between medical test indexes and response and toxic and side effects of malignant tumors immunotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034669
Enrollment
Unknown
Registered
2020-07-14
Start date
2020-08-08
Completion date
Unknown
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant tumor

Interventions

Toxic side reaction group VS non-toxic side reaction group :N/A

Sponsors

The 901st Hospital of Joint Logistics Support Force of PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Malignant tumor confirmed by histology or cytology; 2. Age = 18 years old; 3. Have received immunotherapy in the past (unlimited use times); 4. ECOG PS 0-3 points 5. There is at least one target lesion, which can be evaluated by CT or MRI or other inspection methods 6. Willing to participate in the research and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Active, known or suspected autoimmune diseases; 2. Patients have any doubts about the study or have other risk history.

Design outcomes

Primary

MeasureTime frame
blood count;liver function;renal function;Index mark of cardiac muscle injury;Cardiac function indicator;Inflammatory indicators;Immunological indicators;Endocrine function index;

Secondary

MeasureTime frame
performance status;Body Mass Index;

Countries

China

Contacts

Public ContactWensheng Hao

The 901st Hospital of Joint Logistics Support Force of PLA

hws69@sina.com+86 18909696393

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026